Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | STK10 | O94804 | 1/20 | 0.41 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17487173 | 0.89 | ALDH1A1 (0.45) | ALDH1A1TSHRHSD17B10MAPK1HPGD | |
| SCHEMBL10304455 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TSHRHSD17B10MAPK1HPGD | |
| SCHEMBL10015037 | 0.74 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10MAPK1HPGD | |
| SCHEMBL17487162 | 0.72 | ALDH1A1 (0.58) | ALDH1A1TSHRHSD17B10MAPK1HPGD | |
| SCHEMBL13170970 | 0.72 | ADRA2C (0.46) | ALDH1A1TSHRHSD17B10MAPK1CA1 | |
| SCHEMBL20396041 | 0.72 | ADRA2C (0.54) | ALDH1A1TSHRHSD17B10MAPK1MAOB | |
| SCHEMBL15853175 | 0.72 | ADRA2C (0.54) | ALDH1A1TSHRHSD17B10MAPK1HIF1A | |
| SCHEMBL23348941 | 0.71 | MCL1 (0.47) | ALDH1A1MAPK1CASP1CA1CA2 | |
| SCHEMBL13170957 | 0.70 | PGR (0.48) | ALDH1A1TSHRHSD17B10MAPK1CA1 | |
| SCHEMBL21889361 | 0.70 | ALDH1A1 (0.44) | ALDH1A1TSHRHSD17B10MAPK1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9472766-B2 | Fused polycyclic compound and organic light emitting element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | NR2E3, PUF60, CRY2 | ALDH1A1 897/4885TSHR 3737/4885HSD17B10 972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.